glp-1 and dual glp-1/gip receptor agonists GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Understanding GLP-1 receptor agonists and
Description
Most patients start seeing results around 12 weeks into treatment
November 2023: Canadians filed a proposed class action lawsuit in B.C
The margin of sampling error is plus or minus 3 percentage points for the full sample
Medical providers need a broad spectrum of solutions to address the needs of customers and that includes those with weight challenges
2003 Sep;67((Pt 5)):471485
